secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPLASH BEVERAGE GROUP, INC. (SBEV)
CIK:        0001553788
Form:       8-K
Filed at:   2026-07-06T20:30:33+00:00
Accession:  0001731122-26-000917
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 5.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Splash Beverage Group acquires exclusive worldwide license for CannEpil® epilepsy drug; issues $5.5M Series D preferred
--------------------------------------------------------------------------------

- Exclusive worldwide rights to CannEpil® (CBD/THC) for drug-resistant epilepsy; Licensor gets 15% royalty on net revenue.
- SBEV issues 5,500 shares of Series D Convertible Preferred (stated value $5.5M) to Licensor's noteholder as part of consideration.
- C/M Capital commits to invest at least $1M in SBEV within 60 days; also $1M sales bonus upon $5M cumulative net revenue.
- Development milestones: initiate Phase I trial within 24 months, Phase II within 48 months, file NDA after successful trials.
- Licensor may terminate if SBEV fails to obtain US regulatory approval within 5 years; initial term 20 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226000917/0001731122-26-000917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226000917/e7760_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer